The Indian equity market is set for an eventful Monday, August 31, 2026, with several major companies making headlines. Key developments include a significant leadership change at HDFC Bank, regulatory clearance for Jio Platforms' much-anticipated IPO, and the market debut of Augmont Enterprises. Investors will also be watching updates from Mahindra & Mahindra, pharmaceutical giants Aurobindo Pharma and Cipla, and renewable energy firm Clean Max.
HDFC Bank Announces CEO Retirement
Sashidhar Jagdishan, the current Managing Director and Chief Executive Officer of HDFC Bank, has opted not to seek reappointment. He is slated to retire from his position effective October 26, 2026. The bank's board has initiated a expedited process to select and appoint his successor within the stipulated timeframe, ensuring a smooth leadership transition for the prominent lender.
Jio Platforms IPO Receives SEBI Approval
Jio Platforms (JPL), the telecommunications subsidiary of Reliance Industries, has secured the observation letter from the Securities and Exchange Board of India (SEBI) for its draft red herring prospectus (DRHP). This regulatory clearance paves the way for JPL's proposed initial public offering (IPO), which is anticipated to be India's largest primary stake sale, drawing significant investor interest.
Augmont Enterprises Debuts on Stock Market
Precious metals player Augmont Enterprises is making its stock market debut today, August 31. The company successfully concluded its IPO, which ran from August 21-25, raising a total of Rs 825 crore. Shares were offered at Rs 788 apiece with a lot size of 19 equity shares, and the IPO was notably oversubscribed by 105.78 times, attracting nearly 55 lakh applications.
Mahindra & Mahindra Expands Battery-as-a-Service
Homegrown automotive major Mahindra & Mahindra (M&M) announced the expansion of its innovative Battery-as-a-Service (BaaS) program. This service will now be available across its entire electric-origin SUV portfolio, including the BE 6 SPORTEQ, XEV 9S, and XEV 9e models, enhancing accessibility and flexibility for electric vehicle owners.
Pharmaceutical Sector Updates: Aurobindo Pharma & Cipla
- Aurobindo Pharma: The US Food and Drug Administration (USFDA) conducted an inspection of Unit-VI, an API manufacturing facility belonging to Aurobindo's subsidiary Apitoria Pharma, located in Anakapalli, Andhra Pradesh. The inspection, carried out from August 24 to 28, 2026, concluded with three observations, all noted to be procedural in nature.
- Cipla: The USFDA has classified its inspection of Unit 3, a manufacturing facility of Cipla's US subsidiary InvaGen Pharmaceuticals Inc., as “Voluntary Action Indicated.” The inspection of this facility took place from July 13 to 17, 2026.
NBCC Secures Infrastructure Projects with NHPC
State-run construction firm NBCC has signed a Memorandum of Understanding (MoU) with NHPC for the execution of various infrastructure projects across India. These projects include residential blocks, commercial infrastructure, office complexes, and allied facilities. NBCC will provide project management consultancy (PMC) services for these ventures, earning a fee of 5.5 percent.
Clean Max Energy to Procure 1,550 MW Wind Turbines
Clean Max Enviro Energy Solutions, a renewable energy provider, has received board approval to execute a term sheet with Envision Energy India. This agreement is for the procurement of wind turbine generators (WTGs) for Clean Max's upcoming wind power projects, totaling an aggregate capacity of 1,550 MW. The plan involves procuring 310 WTGs, each with a capacity of 5 MW.
Ola Electric Receives PLI Scheme Incentives
Electric vehicle manufacturer Ola Electric Mobility has been granted a sanction order from the Ministry of Heavy Industries for the release of incentives amounting to Rs 95.81 crore. These incentives fall under the Production Linked Incentive (PLI) Scheme, designed to boost manufacturing in automobiles and auto components, supporting Ola Electric's continued growth.